Feedback
OncLive®
AJMC®
Pharmacy Times®
Specialty Pharmacy Times
  • Biosimilars: The Perfect Fit for Specialty!
  • Price vs Patient Access: Specialty’s Unsettling Conundrum
  • What to Remember About Refill Reminders
  • USP <800>: New Regulations to Protect Health Care Workers from Hazardous Drugs
  • The FDA’s Outsourcing Facility Designation: What It Means and Why It Matters
  • Specialty Pharmacists Play a Vital Part in the Treatment of Hepatitis C
Specialty Drugs Dominate Late-Stage Pipeline
Davy James, Managing Editor
Record number of orphan drugs approved in 2014.
Epilepsy Drug Protects Eyesight of Multiple Sclerosis Patients
Davy James, Managing Editor
Phenytoin helps to reduce damage to the nerve fiber.
Repurposed Anti-Fungal Drug Offers Potential New Prostate Cancer Treatment
Davy James, Managing Editor
Itraconazole shows some promise in treatment of metastatic prostate cancer.
Triumeq by ViiV Healthcare
Michael R. Page, PharmD, RPh
The FDA approved Triumeq (abacavir, dolutegravir, and lamivudine) tablets for the treatment of HIV-1 infection in patients without the HLA-B*5701 allele.
Harvoni by Gilead Sciences, Inc
Michael R. Page, PharmD, RPh
Harvoni is an all-oral treatment of chronic hepatitis C genotype 1 infection in adults.
Featured Video
How Can Specialty Pharmacies Impact Lung Cancer Outcomes?
Donna M. Smith, PharmD, director of clinical affairs at Avella Specialty Pharmacy discusses how specialty pharmacists can help manage difficult lung cancer therapy.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 6
Number: 2
Conference Calendar
       April 2015       
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
2627282930
Featured Company Profile
HIV Pharmacists: Critical Partners on the HIV Care Team
The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2015
Intellisphere, LLC. All Rights Reserved.